OLUWAFISHAYO OMIDELE: Open Payments
NPI 1447635461 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 9 payments from 7 companies in 2025. Trend: 2023 $440 · 2024 $529 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Syndax Pharmaceuticals, Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: ZYNYZ, KISQALI, KEYTRUDA.
Industry payments across TX — which companies pay providers there.
